Abstract Details

Title Trend towards Lowering of Multiple Sclerosis Severity Scores among More Recent Enrollees into the New York State Multiple Sclerosis Consortium

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 070

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mariano Marrodan, MD (Institute for Neurological Research Raul Carrea. Fleni)	Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
	No disclosure on file
Joshua Bacon, PhD (Yeshiva University)	No disclosure on file
Karen Blitz-Shabbir, DO	No disclosure on file
Malcolm H. Gottesman, MD, FAAN (NYU Langone Health)	No disclosure on file
Mustafa Khan, MD (Sevaro Health Inc.)	Dr. Khan has nothing to disclose.

��ɫ��